May 2026
1. KLAUSEN MK, Justesen SK, Pedersen JN, Rasmussen L, et al
   Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial.
   Lancet. 2026;407:1687-1698.
   

   >> Share

   
   October 2025
2. REHM J, Assanangkornchai S, Hendershot CS, Franklin A, et al
   Alcohol use disorders.
   Lancet. 2025 Oct 9:S0140-6736(25)01496-5. doi: 10.1016/S0140-6736(25)01496.
   

   >> Share

   
   November 2024
3. ISRAELSEN M, Francque S, Tsochatzis EA, Krag A, et al
   Steatotic liver disease.
   Lancet. 2024;404:1761-1778.
   

   >> Share

   
   April 2023
4. MAHGOUB S, Newsome PN
   Bariatric-metabolic surgery versus lifestyle intervention in non-alcoholic steatohepatitis.
   Lancet. 2023 Apr 20:S0140-6736(23)00773-0. doi: 10.1016/S0140-6736(23)00773.
   

   >> Share

   
   
5. VERRASTRO O, Panunzi S, Castagneto-Gissey L, De Gaetano A, et al
   Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.
   Lancet. 2023 Apr 20:S0140-6736(23)00634-7. doi: 10.1016/S0140-6736(23)00634.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share